Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

Trial Investigators DREAM; G.R. Dagenais; H.P.F. Koppeschaar; J. Poque; S. Yusuf

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

Translated title of the contribution: Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

Trial Investigators DREAM, G.R. Dagenais, H.P.F. Koppeschaar, J. Poque, S. Yusuf

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
Original language	Undefined/Unknown
Pages (from-to)	1007-1014
Number of pages	8
Journal	Diabetes Care
Volume	31
Issue number	5
Publication status	Published - 2008

Cite this

DREAM, Trial Investigators ; Dagenais, G.R. ; Koppeschaar, H.P.F. et al. / Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. In: Diabetes Care. 2008 ; Vol. 31, No. 5. pp. 1007-1014.

@article{d491ba55af5a4dd2b02157f83cc2a9b2,

title = "Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.",

author = "DREAM, {Trial Investigators} and G.R. Dagenais and H.P.F. Koppeschaar and J. Poque and S. Yusuf",

year = "2008",

language = "Undefined/Unknown",

volume = "31",

pages = "1007--1014",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "5",

}

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. / DREAM, Trial Investigators; Dagenais, G.R.; Koppeschaar, H.P.F. et al.
In: Diabetes Care, Vol. 31, No. 5, 2008, p. 1007-1014.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.

AU - DREAM, Trial Investigators

AU - Dagenais, G.R.

AU - Koppeschaar, H.P.F.

AU - Poque, J.

AU - Yusuf, S.

PY - 2008

Y1 - 2008

M3 - Article

SN - 0149-5992

VL - 31

SP - 1007

EP - 1014

JO - Diabetes Care

JF - Diabetes Care

IS - 5

ER -